학술논문

Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients
Document Type
Journal
Source
JOURNAL OF BUON; JUL-SEP 2013, 18 3, p585-p593, 9p.
Subject
Language
English
ISSN
11070625